Sorrento Therapeutics (SRNEQ)

Sorrento Therapeutics (SRNEQ) Stock Price & Analysis


SRNEQ Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.16 - $3.09
Previous Close$0.32
Average Volume (3M)2.52M
Market Cap
Enterprise Value$291.95M
Total Cash (Recent Filing)$50.32M
Total Debt (Recent Filing)$169.55M
Price to Earnings (P/E)-0.2
Aug 10, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.43
Shares Outstanding547,880,267
10 Day Avg. Volume1,427,414
30 Day Avg. Volume2,521,947
Standard Deviation0.36
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)3.90
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.30
Enterprise Value/Gross Profit9.84
Enterprise Value/Ebitda-0.46
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Sorrento Therapeutics’s price range in the past 12 months?
Sorrento Therapeutics lowest stock price was $0.16 and its highest was $3.09 in the past 12 months.
    What is Sorrento Therapeutics’s market cap?
    Currently, no data Available
    When is Sorrento Therapeutics’s upcoming earnings report date?
    Sorrento Therapeutics’s upcoming earnings report date is Aug 10, 2023 which is in 64 days.
      How were Sorrento Therapeutics’s earnings last quarter?
      Sorrento Therapeutics released its earnings results on May 15, 2023. The company reported -$0.257 earnings per share for the quarter, missing the consensus estimate of -$0.16 by -$0.097.
        Is Sorrento Therapeutics overvalued?
        According to Wall Street analysts Sorrento Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Sorrento Therapeutics pay dividends?
          Sorrento Therapeutics does not currently pay dividends.
          What is Sorrento Therapeutics’s EPS estimate?
          Sorrento Therapeutics’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Sorrento Therapeutics have?
          Sorrento Therapeutics has 551,281,100 shares outstanding.
            What happened to Sorrento Therapeutics’s price movement after its last earnings report?
            Sorrento Therapeutics reported an EPS of -$0.257 in its last earnings report, missing expectations of -$0.16. Following the earnings report the stock price went up 20%.
              Which hedge fund is a major shareholder of Sorrento Therapeutics?
              Among the largest hedge funds holding Sorrento Therapeutics’s share is Graham Capital Management, L.P.. It holds Sorrento Therapeutics’s shares valued at N/A.


                Sorrento Therapeutics Stock Smart Score

                The Sorrento Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Sorrento Therapeutics

                Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.


                Top 5 ETFs holding SRNEQ

                Market Value
                Smart Score
                Fidelity Nasdaq Composite Index ETF
                Up to five ETFs with an Outperform Smart Score that hold SRNEQ. The ETFs are listed according to market value of SRNEQ within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Aptose Biosciences

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis